Abstract:Objective: As the leading factor for female mortality, cervical cancer with high incidence has brought huge burden to both the patients' family and the whole society. So far radiotherapy is the general treatment for cervical cancer. However, radioresistance and metastasis at the advanced stage have become the common cause for its poor prognosis and high mortality. This study aimed to elucidate the role of epidermal growth factor receptor (EGFR) nuclear translocation in radioresistance, and its correlation with the DNA damage repair pathway in cervical cancer cells. Method: In this study, the dynamic expression of EGFR, DNA-dependent protein kinase (DNA-PK) and their phosphorylation level in irradiated cervical cancer cell line CaSki were tested by western blotting. In addition, nuclear localization signal (NLS) peptide inhibitor was synthesized to elucidate the correlation between EGFR translocation and DNA damage repair. Results: The expression of EGFR, protein kinase N1 (PKN1), and DNA-PK in the nucleus increased after irradiation in CaSki cells. Furthermore, irradiation also enhanced the phosphorylation level of EGFR at Thr654, PKN1 at T774 and DNA-PK at T2609. The inhibition of EGFR nuclear translocation decreased the expression level of EGFR and DNA-PK in the nucleus, and attenuated their phosphorylation process. Conclusion: EGFR nuclear translocation promoted DNA damage repair in irradiated cervical cancer cells. This work facilitated the investigators to understand the possible molecular mechanism of the resistance to irradiation in the treatment of cervical cancer, which provided a potentially compelling clinical method for cancer therapy.

Role of nuclear epidermal growth factor receptor in tumorigenesis and resistant to treatment

Nuclear epidermal growth factor receptor as a therapeutic target

Nuclear EGFR:a Potential Target for Radiosensitizer

Role of Epidermal Growth Factor Receptor in Tumor Radiotherapy

The Role of Nrf2-ARE Signal Pathway in Tumorigenesis and Drug Resistance

[Research Progress of the Role of EMT in EGFR-TKIs Resistance of Non-small Cell Lung Cancer].

Epidermal growth factor and its receptor(EGFR)in gastrointestinal tract

Mechanism and Treatment Associated with Resistance to EGFR-TKI

EGFR-TKI Resistance in NSCLC Patients: Mechanisms and Strategies.

Progress of Epidermal Growth Factor Receptor and Tyrosine Kinase Inhibitors in the Cancer Therapy

Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function

The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells

Advances of Research on Vascular Endothelial Growth Factor Receptors in Epidermal Neoplasm

EGFR-Nrf2 pathway plays a role in cancer cell's chemoresistance

The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance

The Inhibition Of Egfr Nuclear Translocation Attenuates Radioresistance Through Decreasing The Expression Of P-Dna-Pk In Cervical Cancer Cells

Involvement Of Egfr In The Promotion Of Malignant Properties In Multidrug Resistant Breast Cancer Cells

Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms

Role of Epiregulin in Lung Tumorigenesis and Therapeutic Resistance

Epithelial Growth Factor Receptor-Activated Nuclear Factor Κb Signaling and Its Role in Epithelial Growth Factor Receptor-Associated Tumors.

Nuclear EGFR in breast cancer suppresses NK cell recruitment and cytotoxicity